Literature DB >> 29175011

Effects of moroxydine hydrochloride and ribavirin on the cellular growth and immune responses by inhibition of GCRV proliferation.

Xiao-Bo Yu1, Kai Hao1, Jing Li1, Xiao-Hui Chen1, Gao-Xue Wang2, Fei Ling3.   

Abstract

Moroxydine hydrochloride (Mor) and ribavirin (Rib) are known for their multi-antiviral activities against DNA and RNA viruses but little information is available about the pharmacological impact in aquaculture. The present study was undertaken to investigate the response of host cells to antiviral compounds during the anti-GCRV treatment. The scanning electron microscope results showed that Ctenopharyngodon idella kidney (CIK) cells have a higher death rate at 72h post virus infection. At the concentration of 40μgmL-1, Mor and Rib had a significant protective effect on virus-infected cells. Moreover, the gene expressions of vp5, vp6 and NS66 were significantly inhibited by treatment with Mor or Rib, especially gene expression of the vp5. For the immunoregulatory action, no distinct induction of the expression of immune genes was observed after the addition of Mor and Rib to the virus-free cells. However, the compounds significantly decreased the virus-induced gene overexpression of Myd88, Mx1, IL-1β, IL-8, I-IFN and TNFα in CIK cells. Moreover, Mor and Rib significantly inhibited the immune genes upregulation which was induced by GCRV in kidney, liver, muscle and gill of grass carp, despite greater partial gene expressions were detected than the virus-free control group. Besides, Mor and Rib blocked cell cycle changes, cytopathic effects, cellular death and virus proliferation in CIK cells thereby maintaining normal morphological structure. Overall, Mor and Rib as antiviral compounds are effective for the control of GCRV replication and the indirectly regulation of cellular immune response.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GCRV; Grass carp; Immune response; Moroxydine hydrochloride; Ribavirin

Mesh:

Substances:

Year:  2017        PMID: 29175011     DOI: 10.1016/j.rvsc.2017.11.007

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  1 in total

1.  Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease.

Authors:  Mahmoud Kandeel; Alaa H M Abdelrahman; Kentaro Oh-Hashi; Abdelazim Ibrahim; Katharigatta N Venugopala; Mohamed A Morsy; Mahmoud A A Ibrahim
Journal:  J Biomol Struct Dyn       Date:  2020-06-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.